Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/03/2007CN101045056A Eyedrops for treating glaucoma and its preparing method
10/03/2007CN101045055A Pipecolic acid-containing antidiabetic compositions
10/03/2007CN101045054A Nimodipime nanometer suspension freeze-dried composition, its preparing method and use
10/03/2007CN101045053A Slow-releasing micro-pills of sophocarpidine and its preparing method
10/03/2007CN101045052A Medicine composition for treating cardiovascular disease
10/03/2007CN101045051A Novel use of tizanidine or its derivatives
10/03/2007CN101045050A Stable antibiotic powder injection
10/03/2007CN101045049A Mutamycine C multivesicular liposome and its preparing method
10/03/2007CN101045048A Application of chondriosome nutrient composition for preventing and treating insulin resistance and biabetes
10/03/2007CN101045047A Liquid composition containing biphenyldimethy-dicarboxylate mutual soluble with water
10/03/2007CN101045046A Use of Brazil hemoatoxy type compound for preparing antineoplastic
10/03/2007CN101045045A Medicine composition containing soya bean aglycone and its preparing method
10/03/2007CN101045044A Thipronin enteric-coated delayed-release agent
10/03/2007CN101045043A Application of glycollic acid for preparing medicine to treat dental deposit
10/03/2007CN101045042A Propofol injection and its preparing method
10/03/2007CN101045041A Cataplasma containing ibuprofen its preparing method and application
10/03/2007CN101045040A Wrapped tablets dichlororeytadin and its preparing method
10/03/2007CN101045039A Dosage form for treatment of diabetes mellitus
10/03/2007CN101045038A Process for preparing gallo lactone freeze-dried powder injection with good solubility
10/03/2007CN101045036A Delayed-release injection containing nitrous carbamide type medicine and topographic enzyme inhibitor
10/03/2007CN101045034A Bioadhesive drug delivery system
10/03/2007CN101044902A Health-care product for reducing weight and lowering cholesterin content in blood
10/03/2007CN100340578C Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof
10/03/2007CN100340575C Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
10/03/2007CN100340570C Solasodine salt of organic acid, its preparation method and application in medicine
10/03/2007CN100340562C Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
10/03/2007CN100340561C Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
10/03/2007CN100340559C Nitrogen containing heterobicycles as factor XA inhibitors
10/03/2007CN100340557C Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340554C Halogen substituted tetracyclic tetrahydrofuran derivatives
10/03/2007CN100340551C 4-(diarylmethyl)-1-piperazinyl derivatives
10/03/2007CN100340548C Novel arylheteroalkylamine derivatives
10/03/2007CN100340545C Tetralone derivatives as antitumor agents
10/03/2007CN100340395C Multilaminate backing construction
10/03/2007CN100340306C Antimicrobial adhesive sheet and antimicrobial method using the same
10/03/2007CN100340297C Anticarcinogenic internal implant agent
10/03/2007CN100340296C Anticarcinogenic internal implant agent
10/03/2007CN100340295C Oral administered compound colloid pectin bismuth preparation and its preparing process
10/03/2007CN100340293C Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
10/03/2007CN100340283C Therapeutic lotion for dermatitis
10/03/2007CN100340268C Synergistic medicinal composition containing tiopronin and Chinese medicine extract
10/03/2007CN100340255C Moutan bark effective constituent and preparation method thereof
10/03/2007CN100340254C Medicine composition for treating malaria
10/03/2007CN100340252C Synergistic medicinal composition containing thiopronin and Chinese medicine extract
10/03/2007CN100340250C Composite propolis soft capsule
10/03/2007CN100340247C Pharmaceutial and/or cosmtic compositions for treatment of localised adiposities and cellulite
10/03/2007CN100340245C Bone strengthening oral liquor and its preparing method
10/03/2007CN100340242C Remedies for diabetes
10/03/2007CN100340241C Eye drop and its preparing method and use
10/03/2007CN100340240C Flunarizine hydrochloride lyophilized agent for injection and its preparing method
10/03/2007CN100340239C Andrographolide dispersing tablets
10/03/2007CN100340238C Curcumin solid dispersion, and its preparing method and use
10/03/2007CN100340237C Transdermal drug delivery system with improved water absorbability and adhesion properties
10/03/2007CN100340231C Itch eliminatin gel and its preparing method
10/03/2007CN100340227C Ceramide emulsions
10/03/2007CN100340217C Nurse glove in medical use and fabricating method
10/03/2007CN100340189C Compound mormula folic acid nutrient supplementing preparation
10/03/2007CN100340186C Himematsutake water soluble polysaccharide and its preparing process and use
10/02/2007USRE39866 Nonpeptide insulin receptor agonists
10/02/2007US7277534 Communications system and method
10/02/2007US7276641 Mixture with analgesic and anti-inflammatory dissolved in an aqueous hot melt type adhesive base material of styrene-isoprene-styrene block copolymer, adhesive resin, an antioxidant, lanolin, and water; drug releasability, good bioavalability
10/02/2007US7276628 Biologically active complex
10/02/2007US7276619 Vitreoretinal silicone tamponades made by supercritical fluid extraction
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007US7276610 Aryl piperidine amides
10/02/2007US7276608 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders
10/02/2007US7276606 Phenantridine analogues and uses thereof
10/02/2007US7276604 Stable in humid environments; bone resorption disorders; mixing and heating an aqueous solution of the salt hydrate with isopropanol and crystallizing during slow cooling
10/02/2007US7276603 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer
10/02/2007US7276602 Isothiazole derivatives useful as anticancer agents
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276592 Nucleotide analogs with six-membered rings
10/02/2007US7276539 In which the phenyl group is p-substituted with a 2-(p-(methylsulfonyloxy)phenoxy)ethyl group; used for treating type 2 diabetes and dyslipidemia; may be combined with atorvastatin, rosuvastatin, or an IBAT inhibitor.
10/02/2007US7276538 Composition and a method for treating hair loss
10/02/2007US7276537 Formulations of anthraquinone derivatives
10/02/2007US7276536 By administering with food; drug is dalcetrapib; use in treatment of cardiovascular disease, coronary heart disease, coronary artery disease
10/02/2007US7276533 Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
10/02/2007US7276532 Incontinence
10/02/2007US7276531 G-lactam derivatives as prostaglandin agonists
10/02/2007US7276530 Lactam fermentation products, e.g., pyrrolooxetanediones or pyrrolothietanediones especially containing a cyclohexane or cyclohexane ring, used as antimicrobial, anticancer or antiinflammatory agents; treating drug resistant cancer
10/02/2007US7276529 Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
10/02/2007US7276528 Compounds for the inhibition of nitric oxide synthase
10/02/2007US7276527 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
10/02/2007US7276526 Comprising a cyclopropyl, and aryl or heteroaryl substitutions; treating neurological and psychological disorders
10/02/2007US7276525 Administering either simultaneously or sequentially a bone morphogenic protein and a compound having a transforming growth factor-beta selective inhibitory activity, particularly 4-(4-benzo[1,3]dioxol-5-yl-5-pyridin-2-yl-1H-imidazol-2-yl)benzamide
10/02/2007US7276524 Compounds as antumor agents or immunosuppressants
10/02/2007US7276523 For therapy and prophylaxis of postmenopausal osteoporosis, estrogen-dependent breast cancer, and cardiovascular disease
10/02/2007US7276522 dextrorotatory and levo-rotatory enantiomers; specific to alpha2B adrenergic receptors
10/02/2007US7276521 Muscarinic acetylcholine receptor antagonists
10/02/2007US7276520 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
10/02/2007US7276519 Anticancer agents; osteoporosis; polycystic kidney disease; antiarthritic agents; organ transplant rejection
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276517 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
10/02/2007US7276516 P-indolyl-, indazolyl- and pyrrolopyridyl-sulfonylbenzamides, e.g., N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; modulators of the Cannabinoid-1 receptor, especially useful for treating obesity
10/02/2007US7276515 Administering optionally hydrogenated 2-alkyl-1-(alkylsulfonylalkyl)imidazo[4,5-c]quinoline-4-amines to induce biosynthesis of IFN-alpha and/or TNF-alpha; treating viral diseases and neoplastic diseases
10/02/2007US7276514 Prevent tissue damage prevent stroke, headaches
10/02/2007US7276513 Steroidal compounds for inhibiting steroid sulphatase
10/02/2007US7276512 anti-tumour properties; surprising in vitro and in vivo cytotoxic activity
10/02/2007US7276511 E.g., N-{2-(3,4-dichlorophenyl)-2-[(3,3-diphenylpropionyl)-methylamino]-4-{spiro[benzo(c)thiophene-1(3H),4'-piperidine]-(2S)-oxide}-1'-yl-butyl}-3,3,3-trifluoro-N-methyl-propionamide hydrochloride, NK-1 or NK-2 receptor antagonists; used to treat irritable bowel syndrome, pain, anxiety and vomiting
1 ... 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575 3576 3577 3578 3579 3580 3581 3582 ... 7860